DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rallied 2.06% to $632.90 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.05% to 7,354.02 and Dow Jones Industrial Average falling 0.09% to 51,876.11.
Regeneron Pharmaceuticals Inc. closed 22.92% short of its 52-week high of $821.11, which the company reached on January 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amgen Inc. $(AMGN)$ rose 1.56% to $358.33, Moderna Inc. (MRNA) rose 12.59% to $67.27, and Gilead Sciences Inc. (GILD) rose 3.26% to $127.88.
Trading volume (1.2 M) eclipsed its 50-day average volume of 1.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 26, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 26, 2026 16:45 ET (20:45 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments